We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$665M
AUM Growth
+$25.6M
(+4%)
Cap. Flow
-$52.2M
Cap. Flow
% of AUM
-7.86%
Top 10 Holdings %
Top 10 Hldgs %
7.74%
Holding
429
New
135
Increased
44
Reduced
92
Closed
135
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CEVA Inc
CEVA
|
+$3.56M |
| 2 |
SN
Sanchez Energy Corporation
SN
|
+$3.52M |
| 3 |
Amphastar Pharmaceuticals
AMPH
|
+$3.48M |
| 4 |
Supernus Pharmaceuticals
SUPN
|
+$3.34M |
| 5 |
Onto Innovation
ONTO
|
+$3.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck India Growth Leaders ETF
GLIN
|
+$7.84M |
| 2 |
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
|
+$6.06M |
| 3 |
NPTN
NEOPHOTONICS CORP
NPTN
|
+$4.84M |
| 4 |
John B. Sanfilippo & Son
JBSS
|
+$4.26M |
| 5 |
PFSW
PFSweb, Inc.
PFSW
|
+$4.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.23% |
| 2 | Healthcare | 17.41% |
| 3 | Industrials | 16.86% |
| 4 | Consumer Discretionary | 12.67% |
| 5 | Materials | 6.07% |
Similar funds
NEPWA
RWM
MCM
HP
OMG
RB
BGC
ICCFIA
EAM Investors's Q2 2016 Portfolio in Review
As of Q2 2016, EAM Investors held 429 positions worth $665M, up 4% from $639M the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.
EAM Investors withdrew a net $52.2M in Q2 2016, closing 135 positions and reducing 92 holdings. Its most notable exit was CELATOR PHARMACEUTICALS INC. COMMON STOCK, an estimated $6.06M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, EAM Investors opened a new position in CEVA Inc worth $3.83M.
- EAM Investors's largest Q2 2016 buy was CEVA Inc: 140,892 shares worth $3.83M.
- EAM Investors added most to Superior Industries International in Q2 2016, an estimated $2.75M increase.
- EAM Investors's biggest Q2 2016 reduction was VanEck India Growth Leaders ETF, cutting an estimated $7.84M.
- EAM Investors fully exited CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016, selling an estimated $6.06M.
- EAM Investors's ten largest holdings make up 7.7% of its $665M portfolio in Q2 2016.
- EAM Investors opened 135 new positions and closed 135 in Q2 2016.
- EAM Investors's portfolio value rose 4% quarter-over-quarter to $665M.
Based on EAM Investors's 13F filing for Q2 2016, filed 4 Aug 2016.